SSYS Q1 2026 Earnings Call Summary | Stock Taper
Logo
SSYS

SSYS — Stratasys Ltd.

NASDAQ


Q1 2026 Earnings Call Summary

May 7, 2026

Summary of Stratasys (SSYS) Q1 2026 Earnings Call

1. Key Financial Results and Metrics

  • Total Revenue: $132.7 million, down 2.4% year-over-year.
  • Product Revenue: $88.8 million (Q1 2025: $93.8 million).
    • System Revenue: $28.8 million (Q1 2025: $31.2 million).
    • Consumables Revenue: $60 million (Q1 2025: $62.6 million).
  • Service Revenue: $43.9 million, up from $42.2 million in Q1 2025, driven by a 23% organic growth in Stratasys Direct.
  • Gross Margin: GAAP gross margin at 41.7% (Q1 2025: 44.3%); Non-GAAP gross margin at 46.3% (Q1 2025: 48.3%).
  • Operating Loss: GAAP operating loss of $26.5 million (Q1 2025: $12.4 million); Non-GAAP operating loss of $3.2 million (Q1 2025: income of $3 million).
  • Net Loss: GAAP net loss of $23.8 million ($0.28 per diluted share) compared to $13.1 million ($0.18 per diluted share) in Q1 2025; Non-GAAP net loss of $1.3 million ($0.01 per diluted share) compared to income of $2.9 million ($0.04 per diluted share).
  • Operating Cash Flow: Generated $2.4 million, maintaining a strong cash position of $237.8 million.

2. Strategic Updates and Business Highlights

  • Growth in Recurring Revenue: Stability from consumables and customer support, with Stratasys Direct showing significant growth.
  • Aerospace and Defense Focus: Strong engagement with U.S. Department of War, with Stratasys Direct shipping over 100,000 parts annually to the defense sector.
  • Regulatory Milestone in Dental: TrueDent Resin received CE Class IIa certification, expanding market opportunities in Europe.
  • Material and Software Innovations: Introduction of ULTEM 1010 resin for aerospace-grade parts and enhancements in software for production efficiency.

3. Forward Guidance and Outlook

  • 2026 Revenue Guidance: Expected range between $565 million to $575 million, with sequential growth anticipated each quarter.
  • Consumables Revenue: Expected to increase over 2025 levels, reflecting confidence in ongoing demand.

4. Bad News, Challenges, or Points of Concern

  • Declining Revenue: Overall revenue decreased year-over-year, with product and consumables revenue both down.
  • Operating Losses: Significant increase in operating losses compared to the previous year, attributed to tariff expenses and foreign currency impacts.
  • Extended Capital Discipline: Customers are exercising caution in capital spending, affecting printer sales timelines.

5. Notable Q&A Insights

  • Defense Opportunities: Strong pipeline in aerospace and defense beyond drones, including munitions and sustainment applications.
  • Transition from Prototyping to Production: Emphasis on manufacturing capabilities with a focus on production parts rather than prototypes.
  • Inorganic Growth Strategy: Plans to leverage a strong balance sheet for acquisitions in high-value, high-requirement applications, avoiding low-margin prototyping markets.
  • Customer Engagement: Increased engagement with major aerospace and defense customers, indicating potential future sales growth.

Overall, while Stratasys faces challenges with declining revenues and increased operating losses, there are positive indicators in strategic growth areas, particularly in defense and dental markets, alongside a strong balance sheet to support future investments.